EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
Industry Body Raises The Alarm Over Energy Costs In Open Letter
Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. It warns that inflation and energy costs threaten European drug makers with closures and rationing.